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Transfusion-related acute lung injury (TRALI) is one of the leading causes of transfusion-related morbidity and 
mortality. However, it is frequently not diagnosed and under-reported, which could result in inappropriate treatment. 
Diagnostic definition for TRALI consists of hypoxia and bilateral pulmonary edema occurring during or within 6 
hours of a transfusion in the absence of cardiac failure or intravascular volume overload. Here, we report a fatal case, 
which resulted from under-recognition and misdiagnosis of TRALI occurring during transfusion with packed red 
blood cells during a bilateral total knee replacement.  (Korean J Anesthesiol 2012; 62: 73-78)
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CC
Homologous blood transfusions cause transfusion reactions 
such as allergic reactions and fervescence, infectious trans  -
mission, acute or delayed hemolytic reactions, and nonhemolytic 
immune reactions [1]. Recently, the Food and Drug Admini-
stration (FDA) reported that transfusion-related acute lung 
injury (TRALI) is one of the leading causes of transfusion-
related morbidity and mortality [2]. However, the reported 
incidence is very rare because of clinical under-recognition and 
misdiagnosis. TRALI is characterized by acute hypoxemia and 
noncardiogenic pulmonary edema that occur within 6 hours 
following a transfusion [3]. Although the condition of 80% of 
the patients improves within 96 hours by means of conservative 
treatment, the current reported mortality rate is 5-10% [4]. 
Death can result if early recognition, diagnosis, and appropriate 
treatment are not done.
Here, we report a fatal case, which resulted from the clinical 
under-recognition and misdiagnosis of a possible case of TRALI 
occurring during transfusion with packed red blood cells (PRBC) 
during a bilateral total knee replacement despite ventilator 
therapy and conservative treatment along with a relevant review 
of the literature.
Case Report
A 73-year-old female patient (Height: 160 cm, weight: 58 kg) 
was diagnosed with degenerative osteoarthritis and admitted 
for bilateral total knee arthroplasty replacement. The patient 
was previously diagnosed and medicated for hypertension for 
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5 years, and diagnosed with suspected angina 5 months prior 
to the surgery receiving aspirin but was discontinued 7 days 
prior to the surgery. Blood and biochemistry tests done prior to 
the surgery were within normal limits. The chest radiography 
examination showed no special findings except cardiomegaly, 
bronchiectasis or nonspecific fibrosis in right lower lung zone. 
Upon electrocardiogram examination and echocardiography, a 
normal sinus rhythm of 66 beats per minute (bpm) along with a 
nonspecific T wave abnormality and about 57% ejection fraction 
without abnormalities of regional wall motion, thrombi, and 
vegetation and normal left atrium and ventricle size, normal 
valve function were revealed.
To perform the surgery under combined spinal epidural 
anesthesia (CSE), 8 mg of 0.5% heavy marcaine (Marcaine, 
Astrazeneca, Sweden) was injected into the subarachnoid space 
using a needle through the needle technique, and 3 ml of a test 
dose using 0.375% of levobupivacaine containing epinephrine (1 
: 200,000) was given following insertion of an epidural catheter. 
Surgery began after sensory blocked level reached the T10 
dermatome and maintained with intermittent injections of 
0.5% levobupivacaine. The patient was monitored using routine 
methods [EKG with ST depression, pulse oximeter (SpO2), 
noninvasive blood pressure, arterial blood pressure, urine 
output (UO), and BIS]. 5 L/min of 100% oxygen was admini-
stered via facemask and monitored SpO2 was 98 to 100%, and 
intermittent midazolam was given for sedation with a BIS level 
of 65 to 80.
The patient remained hemodynamically stable [Blood 
pressure (BP); 130-150/70-85 mmHg, heart rate (HR); 65-85 
bpm, respiration rate (RR); 15-18/min, SpO2; 100%] through 
the intraoperative period immediately before tourniquet release 
of the second knee arthroplasty, and UO was 900 ml during 
the 5 hours procedure. The estimated blood loss was 400 ml, 
and intraoperative fluid replacement consisted of 1,600 ml of 
crystalloid and 500 ml of hetastarch solution. Immediately after 
tourniquet release of the second knee arthroplasty, the patient 
was transfused with PRBC. Twenty-five minutes after tourniquet 
release and initiation of PRBC transfusion, the patient’s blood 
pressure and SpO2 decreased to 87/46 mmHg and 90-95%, 
respectively, with tachypnea and cyanosis so normal saline 
and a second packed RBC transfusion were rapidly replaced 
along with a 5 mg injection of ephedrine. Her arterial blood gas 
analysis (ABGA) showed a pH of 7.32, a PaCO2 of 43 mmHg, 
a PaO2 of 73 mmHg, and oxygen saturation (SaO2) at 93%. At 
the end of the operation (about 30 minutes after transfusion), 
sudden paroxysmal atrial fibrillation developed with systolic 
BP dropping below 70 mm Hg, and a SpO2 of 80% and her 
mental state changed to drowsy with intact light, eyerish, and 
gag reflex upon her neurological examination. Respiration 
and reviving the patient to a conscious state was encouraged, 
but consciousness continually diminished. Since the oxygen 
saturation was reduced to 80% with rigidity of temporomandible 
joint, etomidate and midazolam were injected, and positive 
pressure ventilation was performed using a ventilator after 
endotracheal intubation. The patient’s SpO2 increased to 95-
98%, but pulmonary edema was suspected because a rale 
was heard by auscultation from both lungs in addition to the 
secretion of a frothy sputum. Suddenly, ventricular tachycardia 
occurred and the HR dropped to less than 30 bpm; therefore, 
cardiopulmonary resuscitation was done. After epinephrine 
was injected three times and cardioversions with 200 J biphasic 
waveform shocks, the patient’s rhythm returned to a normal 
state, and thus, a joint diagnosis was done by the Cardiology 
and Neurology Departments. There was no specific abnormal 
findings neurologically, and her transthoracic echocardiography 
in the OR did not show any fine emboli or embolic mass or 
pulmonary hypertension or ventricular dysfunction, but did 
show a decrease in volume and a hyperdynamic status of the 
Fig. 1. Chest radiographs. (A) Preoperative, (B) after intubation and CPR, (C) During critical care in ICU. Chest X-ray shows newly appeared 
bilateral pulmonary infiltrates in (B) and (C) compared with (A).75 www.ekja.org
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heart. Upon portable Chest X-ray examination, it showed 
bilateral pulmonary infiltrates (Fig. 1). The patient was given 20 
mg of furosemide and 500 mg of methylprednisolone IV with 
inotrophic support (dopamine: 5-15 μg/kg/min, Dobutamine: 
5-15 μg/kg/min) and manually assisted ventilation for 
pulmonary edema and 60° semifowel's position, and yet, her 
condition of respiratory insufficiency with frothy secretions did 
not improve over time. She was transferred to ICU for further 
management by department of cardiogy 1 hour after an advent 
event. The femoral vein was catheterized, and we continued to 
focus on treatment for her pulmonary edema, which consisted 
of medical treatment with furosemide, dopamine: (10-20 μg/
kg/min), dobutamine (10-20 μg/kg/min), norepinephrine 
(> 20 μg/kg/min), and volume maintenance using packed 
RBCs and least crystalloid fluid therapy, but copious pinkish 
frothy secretions began to flow out from her tracheal tube, 
and her vital signs and SpO2 were aggravated with anuria and 
DIC. At this time, her ABGA showed a pH of 7.25, a PaCO2 of 
43.8mmHg, a PaO2 of 59.7 mmHg, and a SaO2 of 87.7%. Despite 
her mechanical ventilatory support (FIO2 of 1.0 with PEEP 10-
15 cmH2O) and inotropic treatment, her SpO2 was still low 
(70-90%), and her blood pressure (60-90/40-50 mmHg) was 
unstable and decreased gradually. ABGA, cardiac enzymes 
including N-terminal probrain natriuretic peptide BNP (NT-
proBNP) and Troponin T, and other blood chemistry tests 
were done (Table 1). EKG and TTE also were done reevaluate 
and determine the origin of the pulmonary edema. Her 
cardiac enzymes including Troponin T were slightly increased 
though her NT-proBNP level was within normal limits, her 
transthoracic echocardiography in the ICU did not show any 
signs of heart failure but did show a hyperdynamic and more 
hypovolemic heart. Although she was again given a total of 7 
units of packed RBC for volume maintenance and 2 units of 
FFP for correction of a coagulation abnormality 3 hours after 
the initial adverse event during the ICU stay, her HR began to 
decrease to < 40 bpm. She died 1 hour later despite attempts at 
cardiopulmonary resuscitation.
Discussion
TRALI has often been discussed in the literature as being 
related to transfusions. Since there is no consensus with respect 
to the risk factors and clinical diagnostic criteria of TRALI, 
recognition of it is confused and not easy in most cases, and 
thus, only a small percentage of TRALI cases are published. 
Hence, the incidence of TRALI is estimated to be 0.08-8% 
among patients who undergo transfusions [5,6].
The American European Consensus Conference (AECC) 
modified the definition of TRALI and published it [7], and 
recently, Canadian Consensus conference further modified the 
working group criteria for TRALI [8]. The TRALI was classified 
into “suspected TRALI” and “possible TRALI” and stated that it 
should be differentially diagnosed from transfusion-associated 
circulatory overload (TACO). “Suspected TRALI” is defined 
Table 1. Laboratory Finding before and after Transfusion
Preop
Introperative in OR Postoperative in ICU
Before  
Tfx.
25 min  
after Tfx.
90 min  
after event
180 min  
after event
210 min  
after event
240 min  
after event
pH
PaCO2 (mmHg)
PaO2 (mmHg)
Base excess
HCO3
- (mmol/L)
SaO2 (%)
Hb (g/dl)
Platelet
Troponin T (ng/ml)
Na/K (mEq/L)
NT-proBNP
PT/aPTT
Fibrinogen (mg/dl)
FDP (μg/ml)
D-dimer (μg/L)
Transfusion (Unit)
Treatment
7.47
36.5
93.5
3.0
26.2
97.5
13.1
213 × 10
3
< 0.010 (WNL)
142/4.0
105./25.2
7.40
43
154
-1.0
24.3
99
10.2
136/3.4
7.32
43
73
-3.9
22.2
93
10.2
142/3.6
PRBC 2 
Intubation
†  
7.25
35.8
79.4
-10.8
15.2
94
11.9
0.023 (↑)
142/3.6
217 (WNL)
PRBC 2  
*,†,‡
7.25
43.8
59.7
-8.2
18.6
87.7
11.2
106 × 10
3
148/2.5
16.4/43.7
PRBC 3
†,‡
7.25
42.7
59.6
-8.5
18.1
87.6
16.2
79 × 10
3
18.0/49.2
35 (↓)
127.9 (↑)
18,300 (↑)
PRBC 2
FFP 4
†,‡
6.939
75.9
52.2
-18.1
15.4
67.3
†,‡
Hg: hemoglobin, NT-proBNP: N-terminal probrain natriuretic peptide, PT: prothrombin time, aPTT: activated partial thromboplastin time, 
FDP: fibrin degradation product, WNL: within normal limits, PRBC: packed red blood cells, FFP: fresh frozen plasma. *Cardioversion: biphasic 
200 J→ROSC at 3 min after CPR, 
†semifowerl's position with mechanical ventilator, FiO2 of 1.0, PEEP of 10-15 cmH2O, 
‡used inotrophics with 
dopamine, dobutamine, norepinephrine and epinephrine.76 www.ekja.org
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as a case in which new acute pulmonary damage occurs as 
bilateral diffuse infiltration on a chest radiograph during or 
within six hours after transfusion with a PaO2/FiO2 ratio less 
than 300 mmHg, hypoxemia of SpO2 less than 90% in room 
air, or clinical evidence of hypoxemia in a patient who has not 
showed any evidence of hypertension related to pulmonary 
edema or to the left atrium. A case with clinical circulatory 
overload (e.g. hypertension related to the left atrium) is 
differentially diagnosed as “TACO” . “Possible TRALI” is defined 
by the same diagnostic criteria with those of the suspected 
TRALI, but it refers to the case in which the patient has other 
acute pulmonary risk factors such as sepsis, aspiration, near-
drowning, disseminated intravascular coagulation, trauma, 
pneumonia, drug overdose, fracture, burns, and cardio-
pulmonary bypass in addition to a transfusion. 
It is reported that TRALI occurs within six hours after trans-
fusion, but nonspecific symptoms and signs such as tachypnea, 
frothy pulmonary secretions, hypotension, hyperthermia, 
tachycardia, and cyanosis are found within 30-120 minutes 
after transfusion in most of the cases, and a diffuse rale is 
heard from both sides by auscultation [7,8]. One important 
factor in TRALI diagnosis is that there should be no evidence 
of circulatory overload such as S3 gallop or jugular distension. 
It is known that most of the TRALI patients have euvolemic 
state or may be hypovolemia because of lung parenchymal 
excessive fluid leakage. Since the use of diuretics and rapid 
volume restriction can be the treatment of choice in the case of 
TACO, they can exacerbate hypovolemia. Accurate diagnosis 
is important for proper treatment. TRALI’s CVP, pulmonary 
capillary wedge pressure, and B-natriuretic peptide (BNP) 
values are within the normal ranges. However, TACO and TRALI 
can be differentiated because TACO shows a BNP measurement 
of 100 pg/ml or higher [6,7]. The patient in our case had a NT-
proBNP value of 227 after the occurrence of TRALI, which was 
in the normal range, but hypovolemia was exacerbated by the 
use of diuretics and fluid volume restriction because of the 
misdiagnosis of not TRALI but TACO by physicians in charge. 
Consequentially, her vital sign showed still unstable despite the 
treatment with inotropics and vasoconstrictors, and copious 
pinkish frothy secretions were persisted. Her prognosis became 
worse as the unnecessary transfusion was in addition done to 
correct for unexplained hypovolemia that was later found in the 
echocardiogram without ever knowing causes.
It is generally known that TRALI occurs usually when FFP 
is administered, but it can be caused by all the other blood 
components [4]. The accurate pathogenesis of TRALI is not 
known, but it has been reported that TRALI is related with anti-
HLA I, II, anti-neutrophil antibody, and biologically active lipids 
of the donor plasma [2,6]. Although it is known that TRALI 
pathogenesis is triggered by a trace amount of plasma, the 
relationship between the administered dose and the severity is 
not certain. Rather, hypoxemia is related to the severity. Almost 
nothing is known about the effects of antibody titer, avidity, or 
leukocyte-antigen density on the severity or frequency of TRALI 
reactions, but antibodies were not detected in 17% of the cases 
[9]. Hence, considering the amount of time it takes and the cost 
to obtain results, serological tests are not necessary to diagnose 
a patient; instead, clinical symptoms are used as the diagnostic 
criteria.
The FDA recently recommended that clinicians should be 
alert for TRALI as it publishes its characteristics and morbidity 
[2]. Kopko and Holland [4] insisted that “possible TRALI” 
should be kept in mind primarily when respiratory symptoms 
are accompanied by fever or hypotension within two hours 
follo  wing transfusion. Gajic et al. [6] suggested an approach for 
the management of respiratory patients after blood transfusion 
based on the AECC definition [7]. The approach may be helpful 
to differentiate the diagnosis of TRALI and hydrostatic and 
permeability pulmonary edema, although both can happen 
simultaneously in some cases. 
Generally, for the treatment of TRALI, transfusions should 
be stopped; supplemental oxygen should be administered, 
and auxiliary treatment should be done. It is reported that 
mechanical support is required in most cases. Different from 
acute pulmonary damage due to other causes, recovery is rapid 
with recovery from diffuse pulmonary infiltration known to be 
within 96 h following transfusion in 80% of the cases [4]. The 
efficacy of steroids is still controversial . 
The reason why our case was diagnosed as “possible TRALI” 
was that the possibility of ALI by fat embolism syndrome 
(FES) could hardly be excluded. It is known that FES occurs in 
relationship to many traumatic or nontraumatic conditions, 
but it usually occurs within 24 to 48 hours after lower extre-
mities long bone fracture operations because of the high 
intramedullary pressure occurring during prosthesis implan-
tation [10]. Particularly, FES in total knee replacement arthro-
plasty (TKRA) usually takes place in cemented TKRA that 
employs a long intramedullary stem, and there is a high 
probability of pulmonary fat microembolism, especially in the 
case of bilateral TKRA, in which a tourniquet is installed for 
a long period [10,11]. Since the laboratory and radiographic 
findings are nonspecific, Gurd’s diagnosis criteria based on the 
clinical symptoms are often used. With these criteria [12], FES 
can be diagnosed if the symptoms correspond to one major 
criterion and four minor criteria. In our case, we observed two 
major criteria including symptoms in the respiratory system 
and central nervous system, and other minor criteria such as 
tachycardia, oliguria, thrombocytopenia, and anemia. Various 
changes in brain functions are found in 86% of the patients from 
drowsy to coma. Additionally, it is known that the cutaneous 77 www.ekja.org
Korean J Anesthesiol Kim and Heo
symptom, petechial rash, is found at the conjunctiva, around 
the neck, in the peri-axillary area or upper body within 24-
36 hours in 20-50% of the patients, but it spontaneously 
disappears within one week [10,11]. Additional tests were not 
done to confirm the diagnosis in our case because the patient 
rapidly exacerbated after the symptoms and eventually died 
within 7 hours.
In addition, for the diagnosis of TRALI, we should distinguish 
the changes in hemodynamic status that can develop after 
deflation of a tourniquet or changes that can develop from 
movement of thromboemboli or fat particles from the lower part 
of the body to the right atrium, right ventricle, and pulmonary 
artery [13]. Especially in surgery performed on the lower 
part of the body under combined epidural spinal anesthesia-
sedation with preservation of spontaneous respiration as in our 
case, respiration and metabolic variables from the release of 
the tourniquet were promptly recovered within 3-5 minutes 
from the compensation effect of spontaneous breath [14]. 
However, the recovery of hypotension was slow due to the 
loss of sympathetic tone. The decrease in blood pressure that 
develops after the deflation of the tourniquet was significantly 
low 3 minutes after release due to a loss of blood, reflexive 
vascular relaxation of the ischemic area, and systemic inflow 
of metabolites produced from anaerobic metabolism such as 
adenosine and lactic acid. This can be suppressed up to 15 
minutes after release. However, it is known that any tendency 
of hypotension can be simply managed through vasopressor 
agents. In our patient, the pH, PaCO2, potassium, and lactic 
acid measured after the release of the second TKRA tourniquet 
were within normal range, which rules out the possibility of 
hypotension from the expansion of the blood vessels and 
myocardial depression. In addition, since the last injection 
of the epidural local anesthetic was 55 minutes before the 
deflation of the tourniquet, which was 80 minutes before the 
event occurred, the possibility of sympathetic block influence 
is thought to be negligible. Park and Kim [15] reported that in 
cases of bilateral TKRA, the decrease in cardiac index and mean 
arterial pressure is larger in the second TKRA compared to 
the first; thus, properly maintaining preload is very important. 
When injection of crystalloid is increased to the speed of 20 ml/
kg/h after deflation of the tourniquet and 3 units of PRBC is 
transfused to increase the full load, there were no differences 
in arterial pressure after the deflation of the tourniquet. In our 
case, hypotension and arrhythmia occurred 25 minutes after 
the deflation of the tourniquet; therefore, the volume state of 
the patient was euvolemia, and according to the duration of 
time, we suspected that recovery from tourniquet syndrome 
was possible. In addition, it is necessary to distinguish whether 
it was hydrostatic pulmonary edema from circulatory overload 
or permeability pulmonary edema from ALI to determine the 
cause of hypoxia and pulmonary edema that developed in 
our patient; thus, the possibility of circulatory and respiratory 
suppression from the tourniquet seems unlikely. 
The patient in our case had been taking aspirin since 
angina was suspected by a local clinic because of dyspnea 
that had occurred five months before. The joint diagnosis with 
the Department of Cardiology did not show any distinctive 
cardiovascular symptoms, and the electrocardiography 
and echocardiography did not show any specific findings. 
The cardiac enzyme levels were within the normal limits 
indicating that there would be no specific problems during 
the operation, and the chest pulmonary radiograph did not 
show any findings by which acute pulmonary damage could be 
suspected. However, before the end of the operation, just over 
five hours, that is, 25 minutes after the transfusion, symptoms 
began to appear such as hypotension, tachycardia, and 
cyanosis immediately followed by diminished consciousness, 
tachypnea, frothy pulmonary secretions, and arrhythmia. 
The possibility of “Possible TRALI” was un-recognized and 
misdiagnosed. Since the auxiliary treatment was originally for 
cardiogenic pulmonary edema, we did mechanical ventilator 
therapy, loop diuretics, inotropics, and crystalloids volume 
restriction. Additionally, two or three units of blood were 
transfused to maintain the circulatory volume, and even two 
units of FFP were administered to correct the DIC one hour 
before respiratory arrest occurred. These treatments might have 
exacerbated the symptoms rather than providing conservative 
treatments for the patient.
Conclusively, clinicians should make decisions about 
transfusions for their patients using an appropriate criterion. 
TRALI has been the major cause of transfusion-related 
morbidity and mortality, recently. Differential diagnosis 
of TRALI from TACO and other diseases is difficult since it 
is suspected and diagnosed by the clinical symptoms and 
findings; use of consensus definitions that were recently 
introduced can help to improve the prognosis of TRALI patients 
by doing the diagnosis and treatment early. Moreover, blood 
should be transfused to patients based on strict strategies so 
that transfusion-related complications including TRALI can be 
reduced.
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